News

South Atlantic Bancshares' Strong Q3: Earnings Jump to $0.57

South Atlantic Bancshares' Strong Q3: Earnings Jump to $0.57

South Atlantic Bancshares, Inc. Achieves Significant Earnings Growth

South Atlantic Bancshares, Inc. (OTCQX: SABK), parent of South Atlantic Bank, recently announced that it achieved consolidated net income of $4.4 million, or $0.57 per diluted common share, for the third quarter of 2025. This represents a notable increase from the $3.7 million, or $0.48 per diluted common share, reported in the prior quarter. Over the nine months ending September 30, 2025, the company recorded $11.4 million in net income, translating to $1.48 per diluted common share, up from $6.9 million, or $0.90 per diluted common share, for the same period in 2024.

Quarterly Financial Highlights

Strong Performance Indicators

The third quarter of 2025 marked a significant milestone, reflecting the company's robust performance, highlighted by an 18.9% quarter-over-quarter increase in net income, amounting to an additional $697,000. Compared to the third quarter of 2024, net income soared by $1.8 million, or 68.3%, demonstrating consistent growth within the company.

Additional key financial highlights from the quarter include:

  • Total assets rose by $104.2 million to $1.9 billion, showcasing a healthy annualized growth rate of 7.8% from December 31, 2024.
  • Total loans expanded by $87.6 million, contributing to an annual growth rate of 8.7%.
  • Total deposits increased significantly by $128.0 million, reflecting an annual rate of 11.7%.
  • Tangible book value per share climbed by $1.02, representing a 6.6% increase, reaching $16.49 as of September 30, 2025.

Management Insights

K. Wayne Wicker, Chairman and CEO, attributed these strong results to the ongoing strength of the core banking franchise and disciplined execution across various markets. He noted that while deposit and loan activities remain robust, some seasonal trends temporarily impacted deposit balances. However, favorable trends in credit quality give the company confidence as it heads into the final quarter of the year.

The CEO highlighted a modest decline in loan growth attributable to scheduled payoffs and the timing of transaction closings—factors that align with the company's annual growth expectations, suggesting a sustained positive momentum.

Earnings Summary

Growth in Interest Income

During the three months ending September 30, 2025, South Atlantic Bancshares witnessed an increase in net interest income by $3.1 million or 27.2%, bringing it to $14.6 million compared to $11.5 million during the same period of the previous year. This growth was primarily driven by enhanced yields and organic loan growth.

Despite a decrease in interest income from the company's investment portfolio, the overall financial health remains strong, bolstered by a 27.2% increase in net interest income year-to-date, reaching a total of $40.8 million, compared to $32.1 million the previous year.

Noninterest Income and Expenses

Noninterest income also saw improvements, with a $212,000 increase, reflecting a boost from higher secondary mortgage income and fees. Noninterest expenses rose by $1.4 million, attributed chiefly to higher salaries and employee benefits, as well as other operational costs, reflecting the company’s investments in human resources and technology.

Balance Sheet and Asset Management

As of the end of September 2025, total assets for South Atlantic Bancshares increased to $1.9 billion, a notable rise anchored by growth in the loan portfolio and cash equivalents. The increment in total deposits also illustrates the trust clients place in the bank's services, despite minor reductions in borrowing levels.

Shareholders’ equity stood at $128.6 million, an increase attributed to strong retained earnings and strategic repurchases under the company's stock repurchase program.

Regulatory Capital and Risk Management

The Bank maintains a solid capital position, surpassing the regulatory requirements to be classified as well-capitalized. The total risk-based capital ratio was reported at 12.24%, alongside an 8.86% leverage ratio, signifying financial stability and growth potential moving forward.

Furthermore, the Company continues to manage liquidity prudently, regularly leveraging various financing mechanisms including Pay-Fixed Swap Agreements to hedge against interest rate risks associated with its operations.

Conclusion

The recent announcement from South Atlantic Bancshares, Inc. demonstrates a strong financial performance and resilience in a complex economic landscape. With solid earnings growth, strategic financial management, and a thorough focus on enhancing customer experience, the Bank is well-positioned for continued success in the upcoming quarters.

Frequently Asked Questions

What were the earnings per share for South Atlantic Bancshares?

The earnings per diluted common share for the third quarter of 2025 were reported at $0.57.

How much did total deposits increase during the year?

Total deposits increased by $128.0 million, reflecting an annual growth of 11.7% by September 30, 2025.

What initiatives are taken for risk management?

The company employs Pay-Fixed Swap Agreements to manage interest rate risks associated with its financing operations.

What is the reported total assets of South Atlantic Bancshares?>

The reported total assets have increased to $1.9 billion as of September 30, 2025.

What factors contributed to the increase in noninterest income?

The increase in noninterest income was mainly attributed to enhanced secondary mortgage income, service fees, and increase in merchant income.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 8

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Imaging Techniques for Lung Cancer Treatment Success

Updated Category News Views 37

Revolutionary Techniques in Lung Cancer Management Onc.AI, a leading digital health innovator, is making strides in oncology clinical management with its pioneering approach toward imaging in advanced non-small cell lung cancer (NSCLC). The company focuses on integrating artificial intelligence into healthcare to enhance patient survival rates in cancer treatments....

Continue Reading
Kane Biotech Secures Funding Through Private Placement Initiative

Updated Category News Views 173

Kane Biotech Achieves Significant Milestone with Recent Funding Kane Biotech Inc. has recently made headlines by completing the first closing of its exciting non-brokered private placement offering. This strategic move is set to enhance the company’s capacity to innovate and expand its market presence. Private Placement Offering Details Under this newly announced...

Continue Reading
Apple Adjusts iPhone Air Production Amidst Strong Demand Shift

Updated Category News Views 183

Apple's Strategic Shift in iPhone Production Apple Inc. (NASDAQ:AAPL) has made a significant decision to decrease production orders for its iPhone Air while ramping up production for other flagship models like the iPhone 17. This change comes amid a surge in demand for these devices, particularly in markets that are seeing stronger consumer engagement. Weak Demand Impacts...

Continue Reading
Navigating Legal Proceedings: Insights for RxSight Investors

Updated Category News Views 273

A Comprehensive Guide for RxSight Investors Amid Legal Concerns Investors in RxSight, Inc. should be aware of the growing legal challenges facing the company. Robbins Geller Rudman & Dowd LLP is leading a class action lawsuit aimed at representing those who have faced significant financial losses while investing in RxSight (NASDAQ: RXST). This article delves into the...

Continue Reading
Reusable Laryngoscope System Market Growth Projections for 2034

Updated Category News Views 120

Tremendous Growth in the Reusable Laryngoscope System Market The reusable laryngoscope system market is on track for significant expansion, currently valued at around $920 million in the near term. With the healthcare industry increasingly leaning towards efficient and cost-effective solutions, this market is projected to reach approximately $1.8 billion by the year 2034....

Continue Reading